![Evan Unger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Evan Unger
Fundador en Nuvox Pharma LLC .
Cargos activos de Evan Unger
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Nuvox Pharma LLC
![]() Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Fundador | - | - | |
Presidente | - | - | |
NuvOx Therapeutics, Inc.
![]() NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Fundador | - | - | |
Presidente | - | - |
Historial de carrera de Evan Unger
Antiguos cargos conocidos de Evan Unger.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ImaRx Therapeutics, Inc.
![]() ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Director/Miembro de la Junta | 01/10/1999 | - |
Formación de Evan Unger.
University of California, Berkeley | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Operativa
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Founder | 2 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
ImaRx Therapeutics, Inc.
![]() ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
Nuvox Pharma LLC
![]() Nuvox Pharma LLC Miscellaneous Commercial ServicesCommercial Services Nuvox Pharma LLC operates as biotechnology company. Its publication includes acute hypoxemic respiratory failure, hermorrrhagic shock, mechanism of action, myorcardial infarction, oncology, pharmacokinetics, stroke, and traumatic brain injury. The company was founded by Evan Unger and is headquartered in Tucson, AZ. | Commercial Services |
NuvOx Therapeutics, Inc.
![]() NuvOx Therapeutics, Inc. BiotechnologyHealth Technology NuvOx Therapeutics, Inc. is a clinical stage biotechnology company that develops oxygen therapeutics. The company is based in Tucson, AZ. NuvOx Therapeutics was founded by Jennifer Johnson, Evan C. Unger. Evan C. Unger has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Evan Unger
- Experiencia